NYSE · Healthcare
GLOBUS MEDICAL INC (GMED)
As-reported financials and recent SEC filings for GLOBUS MEDICAL INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$2.94B
Net income
$537.9M
Net margin
18.3%
Diluted EPS
$3.92
ROE
11.8%
P/E (TTM)
20.2×
Market cap
$11.71B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958.1M |
| Gross profit | $1.98B | $1.48B | $1.02B | $759.1M | $718.9M |
| Operating income | $479.8M | $166.0M | $133.1M | $228.0M | $172.0M |
| Net income | $537.9M | $103.0M | $122.9M | $190.2M | $149.2M |
| Diluted EPS | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-09
View on EDGAR →42026-06-08
View on EDGAR →1442026-06-05
View on EDGAR →8-K2026-06-04
View on EDGAR →SD2026-05-27
View on EDGAR →10-Q2026-05-07
View on EDGAR →8-K2026-05-07
View on EDGAR →SCHEDULE 13G2026-04-30
View on EDGAR →Go deeper on GMED
Search GLOBUS MEDICAL INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.